|
C16ORF80 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.472340E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.224410E-04 |
| Normal-vs-Stage2 |
4.451400E-01 |
| Normal-vs-Stage3 |
8.998600E-01 |
| Normal-vs-Stage4 |
8.333800E-01 |
| Stage1-vs-Stage2 |
5.266200E-02 |
| Stage1-vs-Stage3 |
1.201650E-03 |
| Stage1-vs-Stage4 |
3.982200E-03 |
| Stage2-vs-Stage3 |
5.448400E-01 |
| Stage2-vs-Stage4 |
4.266400E-01 |
| Stage3-vs-Stage4 |
7.683000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.160000E-02 |
| Normal-vs-AfricanAmerican |
2.632000E-02 |
| Normal-vs-Asian |
6.112200E-01 |
| Caucasian-vs-AfricanAmerican |
1.543250E-01 |
| Caucasian-vs-Asian |
7.757800E-01 |
| AfricanAmerican-vs-Asian |
7.499000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.297200E-01 |
| Normal-vs-Female |
4.428100E-04 |
| Male-vs-Female |
5.022300E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.664400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.357500E-03 |
| Normal-vs-Age(61-80Yrs) |
2.085400E-01 |
| Normal-vs-Age(81-100Yrs) |
8.922600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.012800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.240400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.125600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.830200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.495000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.929400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.298550E-03 |
| Normal-vs-Grade 2 |
1.377820E-04 |
| Normal-vs-Grade 3 |
5.466400E-01 |
| Normal-vs-Grade 4 |
4.602600E-01 |
| Grade 1-vs-Grade 2 |
4.515800E-03 |
| Grade 1-vs-Grade 3 |
2.36329999999674E-05 |
| Grade 1-vs-Grade 4 |
9.76750000000193E-05 |
| Grade 2-vs-Grade 3 |
1.315310E-03 |
| Grade 2-vs-Grade 4 |
8.414400E-04 |
| Grade 3-vs-Grade 4 |
2.291800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.91960000001301E-06 |
| Normal-vs-ccB subtype |
9.021400E-01 |
| ccA subtype-vs-ccB subtype |
5.50919999999788E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.238300E-02 |
| Normal-vs-N1 |
5.821800E-01 |
| N0-vs-N1 |
2.292800E-01 |
|
|
